SKP2 and breast carcinoma: In the breast cancer cell lines MCF-7 and MDA-MB-231, diosgenin downregulates the expression of Skp2 at both the mRNA and protein levels, thus decreasing breast cancer cell viability and invasion, as well as stimulating apoptosis (Liu et al., 2020b).